Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NT5DC1 pseudogene 2 (NT5DC1P2) is classified as a pseudogene in the human genome[5][6]. Unlike protein-coding genes, pseudogenes do not produce functional proteins and are generally considered nonfunctional genomic elements. There is no evidence that NT5DC1P2 encodes a protein or serves as a receptor, enzyme, transporter, or other therapeutically relevant molecular target[5]. No drugs, disease associations, or biological functions are currently described for this locus in major genetic databases[5][6]. Based on available information, NT5DC1P2 is not a therapeutic target, does not have known biological functions, disease roles, or drug interactions, and is largely ignored in clinical and translational research. The information regarding this target is mostly limited, and its inclusion as a therapeutic target is incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5'-nucleotidase domain containing 1 pseudogene 2 (NT5DC1P2).